{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:21:02Z","timestamp":1754151662709,"version":"3.41.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,19]]},"DOI":"10.7759\/cureus.88312","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T17:39:17Z","timestamp":1752946757000},"source":"Crossref","is-referenced-by-count":0,"title":["A Loss-of-Function Variant Causing Primary Autosomal Recessive Hypertrophic Osteoarthropathy"],"prefix":"10.7759","author":[{"given":"Devanshi N","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sidlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3037-8","article-title":"Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up","volume":"34","author":"T\u00fcys\u00fcz B","year":"2014","unstructured":"T\u00fcys\u00fcz B, Y\u0131lmaz S, Kasap\u00e7opur \u00d6, Erener-Ercan T, Ceyhun E, Bilguvar K, G\u00fcnel M. Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up. Rheumatol Int. 2014, 34:1539-44. 10.1007\/s00296-014-3037-8","journal-title":"Rheumatol Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2022.120171","article-title":"Primary hypertrophic osteoarthropathy - a rare cause of pain and arthritis in children. Description of 5 cases","volume":"47","author":"W\u00f3jtowicz J","year":"2022","unstructured":"W\u00f3jtowicz J, Ko\u0142odziejczyk B, Gazda A, Gietka P. Primary hypertrophic osteoarthropathy - a rare cause of pain and arthritis in children. Description of 5 cases. Cent Eur J Immunol. 2022, 47:280-7. 10.5114\/ceji.2022.120171","journal-title":"Cent Eur J Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ng.153","article-title":"Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy","volume":"40","author":"Uppal S","year":"2008","unstructured":"Uppal S, Diggle CP, Carr IM, et al.. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet. 2008, 40:789-93. 10.1038\/ng.153","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1235040","article-title":"Primary hypertrophic osteoarthropathy: genetics, clinical features and management","volume":"14","author":"Lu Q","year":"2023","unstructured":"Lu Q, Xu Y, Zhang Z, Li S, Zhang Z. Primary hypertrophic osteoarthropathy: genetics, clinical features and management. Front Endocrinol (Lausanne). 2023, 14:1235040. 10.3389\/fendo.2023.1235040","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MCD.0000000000000324","article-title":"Digital clubbing as the predominant manifestation of hypertrophic osteoarthropathy caused by pathogenic variants in HPGD in three Indian families","volume":"29","author":"Radhakrishnan P","year":"2020","unstructured":"Radhakrishnan P, Jacob P, Nayak SS, Gowrishankar K, Prakash Soni J, Shukla A, Girisha KM. Digital clubbing as the predominant manifestation of hypertrophic osteoarthropathy caused by pathogenic variants in HPGD in three Indian families. Clin Dysmorphol. 2020, 29:123-6. 10.1097\/MCD.0000000000000324","journal-title":"Clin Dysmorphol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt958","article-title":"The database of genomic variants: a curated collection of structural variation in the human genome","volume":"42","author":"MacDonald JR","year":"2014","unstructured":"MacDonald JR, Ziman R, Yuen RK, Feuk L, Scherer SW. The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 2014, 42:D986-92. 10.1093\/nar\/gkt958","journal-title":"Nucleic Acids Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2018.10.001","article-title":"Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: a\u00a0single-arm\u00a0intervention trial","volume":"18","author":"Yuan L","year":"2019","unstructured":"Yuan L, Liao RX, Lin YY, et al.. Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: a\u00a0single-arm\u00a0intervention trial. J Orthop Translat. 2019, 18:109-18. 10.1016\/j.jot.2018.10.001","journal-title":"J Orthop Translat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.64000","article-title":"A case study of a female infant with primary hypertrophic osteoarthropathy demonstrates that early initiation of celecoxib slows but does not prevent symptom progression","volume":"197","author":"Zehr K","year":"2025","unstructured":"Zehr K, Buckley M, Owens JW, Vanagunas T, Fernandez PV, Hopkin RJ, Shillington A. A case study of a female infant with primary hypertrophic osteoarthropathy demonstrates that early initiation of celecoxib slows but does not prevent symptom progression. Am J Med Genet A. 2025, 197:e64000. 10.1002\/ajmg.a.64000","journal-title":"Am J Med Genet A"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.12.012","article-title":"Effectiveness of non-steroidal anti-inflammatory drugs among patients with primary hypertrophic osteoarthropathy: a systematic review","volume":"90","author":"Shakya P","year":"2018","unstructured":"Shakya P, Pokhrel KN, Mlunde LB, Tan S, Ota E, Niizeki H. Effectiveness of non-steroidal anti-inflammatory drugs among patients with primary hypertrophic osteoarthropathy: a systematic review. J Dermatol Sci. 2018, 90:21-6. 10.1016\/j.jdermsci.2017.12.012","journal-title":"J Dermatol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03804-5","article-title":"Role of bisphosphonates in hypertrophic osteoarthropathy: a systematic review","volume":"85","author":"Palui R","year":"2024","unstructured":"Palui R, Sridharan K, Sahoo J, et al.. Role of bisphosphonates in hypertrophic osteoarthropathy: a systematic review. Endocrine. 2024, 85:883-93. 10.1007\/s12020-024-03804-5","journal-title":"Endocrine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386945-a-loss-of-function-variant-causing-primary-autosomal-recessive-hypertrophic-osteoarthropathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T17:39:18Z","timestamp":1752946758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386945-a-loss-of-function-variant-causing-primary-autosomal-recessive-hypertrophic-osteoarthropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.88312","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,19]]}}}